study
-
Recon
Knee Arthroplasty Market Is Likely to Reach USD 13928.96 million with Growing CAGR Of 6.00% forecast By 2029
Patients are becoming more aware of the advantages of surgery over alternative forms of treatment including medication and physical therapy,…
Read More » -
Biologics
Zavation releases In-Vitro and In-Vivo Research Summary for its novel “LABYRINTH™”
JACKSON, Miss., Aug. 10, 2022 /PRNewswire/ — Zavation Medical Products (“Zavation” or the “Company”), an innovative designer and manufacturer of spinal implants,…
Read More » -
Spine
SynerFuse™ Announces Fifth Patient Implanted in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study
Study to Evaluate Safety and Tolerability of Simultaneous Implant of Spinal Fusion and Neuromodulation Devices in Chronic Lower Back Pain…
Read More » -
Neuro
InVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgery
Manuscript details patient outcomes through 24-month follow up visit June 8, 2022 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today…
Read More » -
Spine
Study Data Show Premia Spine’s TOPS™ Spinal Arthroplasty System Is Cost-effective Compared With TLIF, Becomes Dominant Strategy Over Time
First-of-a-kind TOPS System designed to offer treatment alternative for patients with spinal stenosis and spondylolisthesis June 2, 2022 NORWALK, Conn.–(BUSINESS…
Read More » -
Spine
InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study
Topline data expected to be reported in Q1 2023 June 2, 2022 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV),…
Read More » -
Spine
Karolinska Development’s portfolio company OssDsign completes patient enrollment to the TOP FUSION study
STOCKHOLM, SWEDEN, April 25, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company OssDsign has enrolled…
Read More » -
Spine
Spineart-100 U.S. Patients Treated In The Single Level IDE Clinical Trial Of BAGUERA®C Cervical Disc Prosthesis
LAGUNA HILLS, Calif., April 21, 2022 /PRNewswire/ — Spineart USA Inc. announced today that surgery has been performed on 100 patients in the single-level U.S.…
Read More » -
Biologics
Bone Therapeutics to strategically focus on lead cell therapy product ALLOB
REGULATED INFORMATION Strategic focus revised and fully focused on achieving topline results of the ALLOB Phase IIb study in tibial…
Read More » -
Spine
New Study Finds Surface Imaging Provides Highly Accurate Models of The Body for Scoliosis Surgeons
The technique, called 3dMD, uses an array of cameras to generate nearly instantaneous images of the torso, which can guide…
Read More »